V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240001374 | 240005515 | 1.77 | 71.4 | Curative (C) | 2019-04-23 | 2019-04-27 | GEMCITABINE + OXALIPLATIN + RITUXIMAB | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101583756 |
| 240001584 | 240005517 | 1.67 | 108 | Curative (C) | 2020-11-30 | 2021-01-02 | CYTARABINE + Gemtuzumab Ozogamicin | 02 | N | CISPLATIN + GEMCITABINE | 100066401 |
| 240001659 | 240005520 | 1.71 | 97 | Curative (C) | null | 2018-03-31 | AML MyeChild 01 A Mitozantrone/Cytarabine | 01 | null | TRIPLE INTRATHECAL | 100079215 |
| 240001691 | 240005521 | 1.73 | 76.3 | Curative (C) | null | 2019-02-25 | Midostaurin | null | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100594207 |
| 240001694 | 240005522 | 0 | 21.2 | null | 2016-09-04 | 2016-09-08 | CAR-T Yescarta + Fludarabine + Cyclophosphamide | 02 | null | ALL UKALL2011 STD BFM CONS B | 100997278 |
| 240001701 | 240005523 | 1.45 | 56.8 | null | null | 2018-03-06 | AML Interim Guidelines FLAG-Ida | null | null | NOT MATCHED | 100051453 |
| 240001703 | 240005524 | 1.68 | 67.7 | 03 | 2018-07-22 | 2018-10-19 | CHOP - 21 days | 02 | N | METHOTREXATE + PEGASPARAGINASE | 100529386 |
| 240001704 | 240005525 | 1.62 | 120 | 03 | 2018-04-04 | 2018-04-14 | Alemtuzumab + Cyclophos TBI Allo | 02 | N | FLAG + IDARUBICIN | 100060121 |
| 240001708 | 240005526 | 1.72 | 12.3 | 03 | 2017-09-01 | 2017-09-08 | Carboplatin + Pemetrexed | 02 | N | GEMTUZUMAB OZOGAMICIN | 100285439 |
| 240001816 | 240005527 | 1.58 | 78.1 | Palliative (P) | 2018-07-25 | 2018-08-19 | null | null | N | AML MYECHILD 01 IT CYT | 101132644 |
| 240001819 | 240005528 | 1.43 | null | null | 2020-10-02 | 2020-10-02 | null | 02 | null | IBRUTINIB | 101391358 |
| 240001828 | 240005529 | null | 60 | 03 | 2017-12-02 | 2017-12-06 | null | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN | 100548346 |
| 240001877 | 240005530 | 1.73 | 79.9 | Curative (C) | null | 2017-03-13 | ALL UKALL2011 Maintenance A1 | null | null | AML MYECHILD 01 HD ARAC | 100172582 |
| 240001955 | 240005532 | 1.69 | 50 | null | 2021-06-21 | 2021-06-24 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | MELPHALAN | 101150207 |
| 240002007 | 240005534 | 1.77 | 69 | Curative (C) | 2018-07-24 | 2018-07-24 | Alemtuz+Fludara+Melphalan RIC MUD | 01 | N | DA | 100038688 |
| 240002031 | 240005536 | 1.65 | 112.75 | Curative (C) | null | 2020-06-29 | ALL UKALL2011 Maintenance A1 | null | null | GEMTUZUMAB OZOGAMICIN | 101860972 |
| 240002152 | 240005538 | 1.65 | 101.4 | null | 2018-06-03 | 2018-06-03 | ICE-R | 01 | null | IDELALISIB + RITUXIMAB | 100343792 |
| 240002164 | 240005539 | 1.69 | 9.95 | null | 2018-01-21 | 2018-02-01 | ALL UKALL2011 Aug BFM Cons C PegAsp | 02 | null | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 101468026 |
| 240002287 | 240005542 | 1.65 | 93.8 | null | 2019-12-10 | 2019-12-20 | R Chlorambucil | 02 | null | IVOSIDENIB | 101567333 |
| 240002338 | 240005543 | 1.66 | 81.9 | Curative (C) | 2018-01-29 | 2018-03-06 | null | 01 | null | TRIPLE INTRATHECAL | 101804494 |
| 240002419 | 240005544 | 1.62 | 84.8 | null | null | 2018-12-24 | CARMUSTINE + THIOTEPA | N | null | GEMCITABINE + PACLITAXEL | 101242152 |
| 240002468 | 240005546 | 0 | 67.4 | null | 2018-06-23 | 2018-06-23 | BORTEZOMIB + THALIDOMIDE | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 101132559 |
| 240002519 | 240005547 | 0 | 27.4 | Disease modification (D) | null | 2018-10-22 | Brentuximab Vedotin | 01 | null | GEMCITABINE + PACLITAXEL | 101262604 |
| 240002662 | 240005550 | 1.8 | 14 | null | 2019-12-03 | 2019-12-03 | null | 02 | null | CYTARABINE HIGH DOSE | 100465389 |
| 240002737 | 240005551 | 1.75 | 45 | Curative (C) | null | 2020-04-21 | null | null | null | RUXOLITINIB | 100926406 |
| 240002740 | 240005552 | 1.72 | 9.95 | 03 | 2019-12-20 | 2019-12-25 | ALL UKALL2011 Del Int C Recon PAsp | 02 | N | CYTARABINE + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 100530577 |
| 240002801 | 240005554 | 1.6 | 77.7 | Curative (C) | 2020-06-17 | 2020-08-02 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CYCLOPHOSPHAMIDE | 100815906 |
| 240002809 | 240005555 | 1.62 | 66.7 | null | null | 2018-07-19 | ALL UKALL2011 Aug BFM Cons C PegAsp | null | null | AML MYECHILD 01 A MITOZANTRONE/CYTARABINE | 100400639 |
| 240000178 | 240005558 | 1.73 | 69 | null | 2015-02-10 | 2018-05-25 | FLAIR trial | 02 | null | MIDOSTAURIN | 101441540 |
| 240000200 | 240005559 | 1.81 | 69.8 | 03 | 2016-09-25 | 2016-12-30 | null | 01 | N | IMATINIB | 100986903 |
| 240000359 | 240005560 | 1.82 | 75 | null | 2019-09-11 | 2019-09-15 | null | 02 | null | RUXOLITINIB | 100257248 |
| 240001287 | 240005565 | 1.68 | 58.5 | Curative (C) | 2019-11-09 | 2019-12-18 | R-GDP | 02 | N | NOT MATCHED | 100843054 |
| 240001581 | 240005566 | null | 52.5 | Curative (C) | 2019-08-15 | 2019-08-15 | Acalabrutinib | 02 | null | R CODOX-M/ R IVAC | 100376249 |
| 240002468 | 240005568 | 1.69 | 64.2 | null | 2019-03-17 | 2019-03-17 | ALL UKALL2011 Ind B Sht Dex (PAsp) | 02 | null | BENDAMUSTINE | 101132559 |
| 240000929 | 240006076 | 1.7 | 48 | null | null | 2019-09-17 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100954993 |
| 240000931 | 240006077 | null | null | null | null | 2017-11-15 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100881006 |
| 240000939 | 240006080 | null | null | null | 2018-02-19 | 2018-02-19 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101248106 |
| 240000949 | 240006085 | null | null | null | null | 2017-03-29 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100796352 |
| 240001101 | 240006167 | 1.61 | 76 | null | null | 2020-09-09 | CHOP R - 21 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100498941 |
| 240001128 | 240006175 | null | null | Palliative (P) | null | 2016-03-19 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100562267 |
| 240001166 | 240006191 | null | null | null | null | 2017-12-19 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100896977 |
| 240001179 | 240006198 | null | null | null | null | 2019-03-10 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101083954 |
| 240001207 | 240006213 | null | null | null | null | 2016-10-18 | CHOP R - 21 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100621386 |
| 240001262 | 240006250 | null | null | null | null | 2017-05-21 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100963728 |
| 240001264 | 240006252 | null | null | null | null | 2017-04-16 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101864912 |
| 240001277 | 240006264 | null | null | null | null | 2019-06-12 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100722782 |
| 240001284 | 240006271 | null | null | null | null | 2018-10-20 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101482690 |
| 240001300 | 240006283 | null | null | null | null | 2019-02-05 | CHOP R - 21 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100249040 |
| 240001316 | 240006296 | null | null | Curative (C) | null | 2019-09-28 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101822694 |
| 240001346 | 240006319 | null | null | null | null | 2018-03-28 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100826591 |